Evidence map›Paper›PMID 39298723›Full record

ArticleArquivos brasileiros de oftalmologia2023

PRPH2 mutation c.582-1G>A causing adult-onset macular dystrophy with a benign concentric annular macular dystrophy phenotype in a family.

Karina Fernández-Berdasco, José Galvez-Olortegui, Sussan's Pamela Guillén-Lozada, Noelia García González, Joaquín Castro-Navarro

Abstract readCase ReportsLetter
In one paragraph

Article in Arquivos brasileiros de oftalmologia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Karina Fernández-BerdascoOphthalmology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.ORCID 0000-0001-8080-6431
José Galvez-OlorteguiOphthalmology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.ORCID 0000-0003-1818-9801
Sussan's Pamela Guillén-LozadaOphthalmology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.ORCID 0000-0002-7079-6855
Noelia García GonzálezGenetics Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
Joaquín Castro-NavarroOphthalmology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The peripherin gene (PRPH2) mutation is associated with photoreceptor cell dysfunction as well as in several inherited retinal dystrophies. The PRPH2 mutation c.582-1G>A is a rare variant reported in retinitis pigmentosa and pattern dystrophy. Here Case 1 was of a 54-year-old woman with bilateral atrophy of the perifoveal retinal pigmentary epithelium and choriocapillaris with central foveolar respect. Autofluorescence and fluorescein angiography revealed perifoveal atrophy of the retinal pigmentary epithelium with an annular window effect without the "dark choroid" sign. Case 2 (mother of Case 1) presented with extensive atrophy of the retinal pigmentary epithelium and choriocapillaris. PRPH2 was evaluated and the c.582-1G>A mutation was identified in heterozygosity. An advanced adult-onset benign concentric annular macular dystrophy diagnosis was thereby proposed. The c.582-1G>A mutation is poorly known and not present in all common genomic databases. This case report is the first one to report a c.582-1G>A mutation associated with benign concentric annular macular dystrophy.

Indexed as

Fluorescein AngiographyMacular DegenerationMutationPeripherinsPhenotypeFemaleHumansMiddle AgedPedigreeRetinal Pigment EpitheliumTomography, Optical CoherencePeripherinsPRPH2 protein, human

Identifiers

PMID39298723
PMCPMC11623322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.